Monoamine oxidase gene transcription in human cell lines: Treatment with psychoactive drugs and ethanol

Journal of Neural Transmission

Volumn 103, Issue 6, 1996, Pages 681-692

  Ekblom, J ^a   Zhu, Q S ^a   Chen, K ^a   Shih, J C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alcohol; Growth hormone; Neuroblastoma; Promoter; Reporter gene

Indexed keywords

ALCOHOL; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; LITHIUM CHLORIDE; PHENETHYLAMINE; PSYCHOTROPIC AGENT; RACLOPRIDE; SELEGILINE; SEROTONIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL LINE; CELL SPECIFICITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE;

ALCOHOL DRINKING; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS; ETHANOL; HUMANS; LITHIUM CHLORIDE; MONOAMINE OXIDASE; MONOAMINE OXIDASE INHIBITORS; NEUROBLASTOMA; PROMOTER REGIONS (GENETICS); PSYCHOTROPIC DRUGS; RACLOPRIDE; SALICYLAMIDES; SELEGILINE; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0029851581     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271228     Document Type: Article

References (28)

1. Aliyu SU, Upahi L (1988) In vivo relationship between monoamine oxidase type B and alcohol dehydrogenase: effects of ethanol and phenylethylamine. Life Sci 43: 345-356
2. Anokhina IP, Ovchinnikova LN, Khristolyobova NA, Gorkin VZ (1990) Evidence for impairment of liver monoamine oxidase properties of offspring of alcoholized rats. Biogen Amines 7: 95-105
3. Bach AW, Lan NC, Johnson DL, Abell CW, Bembenek ME, Kwan SW, Seeburg PH, Shih JC (1988) cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc Natl Acad Sci USA 85: 4934-4938
4. Baron M, Gruen R, Levitt M, Kane J (1982) Neuroleptic drug effect of platelet monoamine oxidase and plasma amine oxidase in schizophrenia. Psychiatry Res 7: 192-187
5. Biedler JL, Roffler-Tarlov S, Schachner M, Freedman LS (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res 38: 3751-3757
6. Bockar J, Roth R, Heninger G (1974) Increased human platelet monoamine oxidase activity during lithium carbonate therapy. Life Sci 15: 2109-2118
7. Chen C, Okayama H (1986) High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7: 2745-2752
8. Chojnacki M, Kralik P, Allen RH, Ho BT, Schoolar JC, Smith RC (1981) Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients. Am J Psychiatry 138: 838-840
9. Dawood I, Welch W Jr (1979) The stimulation of rat monoamine oxidase by dietary lithium chloride. Experientia 35: 991-992
10. DeLisi LE, Neckers LM, Staub RA, Zalcman SJ, Wyatt RJ (1980) Lymphocyte monoamine oxidase activity and chronic schizophrenia. Psychiatry Res 2: 179-186
11. Denney RM, Sharma A, Dave SK, Waguespack A (1994) A new look at the promoter of the human monoamine oxidase A gene: mapping transcription initiation sites and capacity to drive luciferase expression. J Neurochem 63: 843-856
12. Dignam JD, Lebovites RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 11: 1475-1489
13. Grimsby J, Chen K, Wang L, Lan NC, Shin JC (1991) Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA 88: 3637-3641
14. Huang LG, Bowden CL (1984) Platelet monoamine oxidase response to lithium treatment in psychiatric patients. J Clin Psychopharmacol 4: 326-331
15. Jackman HL, Meltzer HY (1980) Factors affecting determination of platelet monoamine oxidase activity. Schizophr Bull 6: 259-266
16. Lan NC, Heinzmann C, Gal A, Klisak I, Orth U, Lai E, Grimsby J, Sparkes RS, Mohandas T, Shih JC (1989) Human monoamine oxidase A and B genes map to Xp11.23 and are deleted in a patient with Norrie's disease. Genomics 4: 552-559
17. Lowry O, Rosebrough N, Farr A, Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
18. Medina JL, Fareed J, Diamond S (1980) Lithium carbonate therapy tor cluster headache. Changes in number of platelets, serotonin and histamine levels. Arch Neurol 37: 559-563
19. Nevo I, Parvez S (1994) Changes in brain MAO activity and glycogen levels upon chronic alcoholization of three successive generations of rats. Fundam Clin Pharmacol 8:347-355
20. Sambrook J, Fritsh EF, Maniatis T (1989) Molecular cloning - a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor
21. Selden RF, Burke-Howie K, Rowe ME, Goodman HM, Moore DD (1986) Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol Cell Biol 6: 3173-3179
22. Shih J, Lan N, Bach A, Burke D, Bembenek A-M, Kwan A-W, Abell AC, Seeburg P (1988) cDNA cloning of human liver MAO-A and -B. Pharmacol Res Commun [Suppl] 20: 7
23. Sullivan JL, Cavener JO, Stanfield CN, Hammett EB (1978) Reduced MAO activity in platelets and lymphocytes of chronic schizophrenics. Am J Psychiatry 135: 597-598
24. Tabakoff B, Lee JM, De-Leon-Jones F, Hoffman PL (1985) Ethanol inhibits the activity of the B-form of monoamine oxidase in human platelet and brain tissue. Psychopharmacol (Berlin) 87: 152-156
25. Vidal M, Morris R, Grosveld F, Spanopoulou E (1990) Tissue-specific control elements of the Thy-1 gene. EMBO J 9: 833-840
26. Weyler W, Hsu Y, Breakfield X (1990) Biochemistry and genetics of monoamine oxidase. Pharm Ther (England) 47: 391-417
27. Zhu Q-S, Grimsby J, Chen K, Shih JC (1992) Promoter organization and activity of human monoamine oxidase (MAO) A and B genes. J Neurosci 12: 4437-4446
28. Zhu Q-S, Chen K, Shih JC (1994) Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 14: 7393-7403